Blood plasma with coronavirus antibodies will be tested for use on seriously ill patients, and test for Coronavirus survivors, now immune to the virus, could allow them to resume work.
$4.2 billion synthetic biology powerhouse Ginkgo Bioworks is giving $25 million worth of resources in their $400 million R&D facility to public and private teams working to cure, prevent and treat the novel coronavirus.
Surgeon General Jerome Adams called on young people Thursday during the White House press briefing to donate blood as the American Red Cross faces a “severe blood shortage” amid social distancing guidelines.
A group of 300-plus engineers, designers, tech founders and others galvanized on Facebook with a goal of building a ventilator using readily available materials, 3D printing and open-source hardware resources.